Aspirin risks in perspective: a comparison against marathon running

Morgan, Gareth 2014. Aspirin risks in perspective: a comparison against marathon running. Health Education Journal 73 (4) , pp. 491-493. 10.1177/0017896912471102

Full text not available from this repository.

Abstract

Aspirin has public health potential to reduce the risk of ischaemic vascular events and sporadic cancer. One objection to the wider use of aspirin for primary prevention, however, is the undesirable effects of the medicine, which include increasing risk of bleeding and haemorrhagic stroke. Marathons also carry risks of serious events such as cardiac arrests and sudden death. Based on epidemiological estimates, a person running a marathon might be 20 to 100 times more likely to end up in hospital than a person who is taking an aspirin tablet. Yet the cumulative risk of daily aspirin use for primary prophylaxis may be important. One option open to middle-aged individuals who want to take aspirin is to start with an infrequent regime, such as once per week, in order to then build to daily use. It is important to get all concerns into perspective and comparisons can offer a challenge to any excessive risk aversion regarding the public health potential of aspirin.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Subjects:	R Medicine > R Medicine (General)
Publisher:	Sage
ISSN:	0017-8969
Last Modified:	27 Mar 2019 15:23
URI:	https://orca.cardiff.ac.uk/id/eprint/79266

Actions (repository staff only)

Edit Item